Harvard Catalyst brings together the intellectual force, technologies, and clinical expertise of Harvard University and its affiliates and partners to reduce the burden of human illness.
Harvard Catalyst | The Harvard Clinical and Translational Science Center is supported by the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program (grant 1UL1 TR001102-01), and with contributions from Harvard University, Harvard Medical School, Harvard School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Massachusetts General Hospital. The NIH CTSA program is led by the National Center for Advancing Translational Sciences (NCATS). Founded in 2008, Harvard Catalyst is dedicated to improving human health by enabling collaboration and providing tools, training, and technologies to clinical and translational investigators. As a shared enterprise of Harvard University, Harvard Catalyst resources are available to all Harvard faculty, regardless of institutional affiliation or academic degree.
The content of this website is solely the responsibility of Harvard Catalyst and does not necessarily represent the official views of the NIH.